… to enhance dapagliflozin-induced weight loss by preventing … to dapagliflozin treatment, and
if so, whether prevention of hyperphagia would enhance dapagliflozin-induced weight loss in …

… weight, fasting plasma glucose, and urinary glucose excretion. After 12 weeks of dapagliflozin
treatment, A1c reduction, weight loss… the A1c reduction after dapagliflozin treatment with a …

… In conclusion, dapagliflozin-mediated weight loss may … in weight is of benefit in patients
with diabetes 2. This analysis aimed to evaluate whether dapagliflozin-induced weight loss …

… Dapagliflozin patients had significantly greater weight loss … of dapagliflozin-treated patients
reporting ongoing weight loss … 24, 50 and 102) than placebo-treated patients. In a post-hoc …

… Finally, we aim to investigate if dapagliflozin treatment increases insulin and glucagon
secretion in patients with obesity. Chronic hyperglycemia leads to a defect in insulin production …

… We have reported both analyses to evaluate the robustness of dapagliflozin treatment effects
and found that the adjusted mean changes from baseline in HbA 1c were similar between …

… Furthermore, the reduction of EAT volume might also be achieved with weight loss alone.
Therefore, this effect might not be specific to dapagliflozin. Fourth, the present study evaluated …

… In addition, dapagliflozin treatment facilitated weight loss in patients with T2DM by inducing
controlled glucosuria. Small changes in lipid levels, not likely to be of clinical significance, as …

… A particular benefit of dapagliflozin has been its ability to promote weight loss. Studies have
… •• This study reported on the efficacy and safety of dapagliflozin treatment in patients on …

… of dapagliflozin further reduced HbA 1c levels and mitigated the pioglitazone-related weight
gain … urinary excretion of glucose with modest caloric elimination leading to weight loss (2,3). …